Molecular mechanism of ophiopogonin B induced cellular autophagy of human cervical cancer HeLa cells

Yaoxue Xuebao

Volumn 48, Issue 6, 2013, Pages 855-859

  Xu, Qiu Ju ^a   Hou, Li Li ^a   Hu, Guo Qiang ^a   Xie, Song Qiang ^a  

^a HENAN UNIVERSITY   (China)

Author keywords

Akt; Antitumor; Apoptosis; Autophagy; Ophiopogonin B

Indexed keywords

ANTINEOPLASTIC AGENT; BECLIN 1; MAMMALIAN TARGET OF RAPAMYCIN; OPHIOPOGONIN B; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; 3-METHYLADENINE; ADENINE; APOPTOSIS REGULATORY PROTEIN; BECN1 PROTEIN, HUMAN; LIGHT CHAIN 3, HUMAN; MAP1LC3A PROTEIN, HUMAN; MEMBRANE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; MTOR PROTEIN, HUMAN; OPHIOPOGON ROOT; PTEN PROTEIN, HUMAN; S6 KINASE; SAPONIN; SPIROSTAN DERIVATIVE; TARGET OF RAPAMYCIN KINASE;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; DRUG MECHANISM; FLOW CYTOMETRY; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STAINING; UPREGULATION; UTERINE CERVIX CARCINOMA; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; HELA CELL LINE; MEDICINAL PLANT; METABOLISM; PHOSPHORYLATION;

ADENINE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HELA CELLS; HUMANS; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; OPHIOPOGON; PHOSPHORYLATION; PLANTS, MEDICINAL; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SAPONINS; SIGNAL TRANSDUCTION; SPIROSTANS; TOR SERINE-THREONINE KINASES; UP-REGULATION;

EID: 84882393274     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Shigetomi H, Higashiura Y, Kajihara H, et al. Targeted molecular therapies for ovarian cancer: an update and future perspectives [J], Oncol Rep, 2012, 28:395-408.
2. Lieberman AP, Puertollano R, Raben N, et al. Autophagy in lysosomal storage disorders [J], Autophagy, 2012, 8:719-730.
3. Carew JS, Kelly KR, Nawrocki ST. Autophagy as a target for cancer therapy: new developments [J], Cancer Manag Res, 2012, 4:357-365.
4. Zhang JQ, Li YM, Liu T, et al. Antitumor effect of matrine in human hepatoma G2 cells by inducing apoptosis and autophagy [J], World J Gastroenterol, 2010, 16:4281-4290.
5. Qiao C, Shinichi T, Satoshi O, et al. Mechanism of down regulation of apoptosis by autophagy induced by oridinin in HeLa cell [J], Acta Pharm Sin, 2007, 42:35-39.
6. Yu XK. The pharmacological progression of Radix Ophiopogon Japonicus [J], Tianjin Pharm, 2012, 24:69-70.
7. Shu QJ, Wu LC. Experimental research on treatment of cancer with "Xinjiashashenmaidong Decoction" [J], China J Basic Med Tradit Chin Med, 2002, 8:34-36.
8. Xie SQ, Zhang LL, Yang T, et al. Acetylsalicylic acid strengthens the effects of ANISpm against hepatocellular carcinoma and its molecular mechanism [J], Acta Pharm Sin 2011, 46:1045-1050.
9. Zhu MY, Wang RB, Zhou W, et al. Antitumor effect research progress of shikonin and its derivatives [J], Acta Pharm Sin, 2012, 47:588-593.
10. Xie SQ, Zhang YH, Li Q, et al. 3-Nitro-naphthalimide and nitrogen mustard conjugate NNM-25 induces hepatocellular carcinoma apoptosis via PARP-l/p53 pathway [J], Apoptosis, 2012, 17:725-734.
11. Zhang X, Chen LX, Ouyang L, et al. Plant natural compounds: targeting pathways of autophagy as anti-cancer therapeutic agents [J], Cell Prolif, 2012, 45:466-476.
12. Zhang Y, Yang ND, Zhou F, et al. (-)-Epigallocatechin-3-gallate induces non-apoptotic cell death in human cancer cells via ROS-mediated lysosomal membrane permeabilization [J], PLoS One, 2012, 7:e46749.
13. Hundeshagen P, Hamacher-Brady A, Eils R, et al. Concurrent detection of autolysosome formation and lysosomal degradation by flow cytometry in a high-content screen for inducers of autophagy [J], BMC Biol, 2011, 9:38.
14. Zou CY, Smith KD, Zhu QS, et al. Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumor [J]. Mol Cancer Ther, 2009, 8:1157-1168.